32 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jan 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
15
Ending by 2030
Jan 2027
Next term end
3
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends no later than Feb 2030 · Medium confidence
Also notable
Ends Sep 2039 · High confidence
Nucleic Acid Purification
US 9,012,208
The most cited patent in this portfolio, cited by 147 later US patents, top 5% of utility patents granted in 2015 in our data. Protection runs to 2030. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Multiplexed Fuel Analysis
US 12,529,111
A family of 6 related applications built on the 2026 grant. Too new for citation comparison; protection runs to 2039.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due May 3 to 5, 2027 · next May 3
- 1 fee due Jul 21, 2027The maintenance fee for Methods for Forensic DNA Quantitation (US 10,538,804) comes due Jul 21, 2027. Unpaid by Jan 21, 2028, it lapses early.
- 1 fee due Aug 13, 2027The maintenance fee for An Adaptive Expert System for Analysis and Classification of DNA Sample Data (US 11,900,604) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
- 2 fees due Oct 12 to 19, 2027 · next Oct 12
Recent changes
- 1 of the patents on this record was granted since Aug 19, 2026
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Plastic microfluidic separation and detection platforms | 29 in force | to Sep 2040 |
| Multiplexed Fuel Analysis | 2 in force | to Nov 2041 |
| An Adaptive Expert System for Analysis and Classification of DNA Sample Data | 1 in force | to Jan 2042 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,173,417 | Ruggedized Apparatus for Analysis of Nucleic Acid and Proteins In force · Medium confidence | In force | Medium confidence | |
| US 8,961,765 | Plastic Microfluidic Separation and Detection Platforms In force · High confidence | In force | High confidence | |
| US 9,366,631 | Integrated Systems for the Multiplexed Amplification and Detection of Six and Greater Dye Labeled Fragments In force · High confidence | In force | High confidence | |
| US 9,494,519 | Methods for Rapid Multiplexed Amplification of Target Nucleic Acids In force · High confidence | In force | High confidence | |
| US 9,889,449 | Integrated Systems for the Multiplexed Amplification and Detection of Six and Greater Dye Labeled Fragments In force · High confidence | In force | High confidence | |
| US 9,994,895 | Plastic Microfluidic Separation and Detection Platforms In force · High confidence | In force | High confidence | |
| US 11,052,398 | Plastic Microfluidic Separation and Detection Platforms In force · High confidence | In force | High confidence | |
| US 11,110,461 | Integrated Nucleic Acid Analysis In force · High confidence | In force | High confidence | |
| US 8,425,861 | Methods for Rapid Multiplexed Amplification of Target Nucleic Acids In force · High confidence | In force | High confidence | |
| US 9,012,208 | Nucleic Acid Purification In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 32: 4 patents ended · 5 applications pending · 11 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
3 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed